Meet Augnito at UKIO 2022 – a next-gen speech recognition technology centred on disruptive innovation
[London, 23 June 2022] – In 1962 the first speech recognition* (SR) technology could recognise just 16 words in English. Fast forward 60 years and SR is built into most elements of our daily lives. And yet in healthcare, SR solutions are not used to their full potential, until now – there is a new voice-driven AI product suite is offering a more accurate alternative.
UKIO is back as a face-to-face event with a refreshed 3-day congress, programme and exhibition that will showcase the latest state-of-the-art equipment, services, technology and content aimed at addressing issues in the fields of diagnostic imaging, oncology, and radiology. This year’s theme ‘Harnessing disruption: Clinical excellence in a time of chaos’ mirrors the innovation and technology behind Augnito – a next gen clinical speech recognition solution introduced to the UK healthcare market last Autumn.
Since its launch Augnito has already recorded positive sales and trading interest. Born from Scribetech’s 20 year partnership with the NHS to promote patient data accuracy and clinician efficiency benefits, the Augnito speech recognition product suite has secured over 150 installations in healthcare environments across England.
More recently the Augnito team have been sharing their success with industry partners in the radiology sector while celebrating a number of live pilots and positive implementations that have taken advantage of the speech-enabling benefits provided by the Augnito API & SDK solution.
Shiraz Austin, Co-Founder for Augnito comments, “Augnito was built from the ground up in collaboration with engineers, analysts, and clinicians to offer an alternative to the legacy speech recognition products currently available on the market. With extensive transcription experience, 8 years R&D, disruptive innovation technology and a true commitment to clinicians’ needs, we are proud to offer a highly accurate, secure, cloud-based, portable and cost effective alternative”.
Radiology departments have been the early adopters of speech recognition technology to accommodate the ever-increasing levels of diagnostic reporting and the -expanding modality spectrum. Augnito offers this sector an improved, more efficient way, to deliver their service using the streamlining benefits that come with voice-driven AI technology.
“Augnito partners are as critical for its continued market growth, just as Augnito is a key contributor to its partners’ success in speech enabling clinical systems and effectively accelerating digital transformation in the healthcare sector. Augnito offers partners a unique cloud-based technology, which they can easily integrate and rapidly deploy, not just to improve the productivity of busy customers and reduce the cost of clinical documentation, but to also gain healthy business resell margins.”
“Augnito’s aim is to democratize the use of clinical speech recognition software through a selective network of ISVs, VARs, and managed service providers that have a healthcare focus. Augnito also provides services, support and guidance, to partners’ customers either considering, implementing, or already ‘live’ on a medical information system.” concludes Austin.
Augnito can be seen in action, integrated into different clinical reporting platforms at UKIO in Liverpool, 4-6 July, on its attending partner stands; Hexarad A28, Wellbeing Software B45 Fujifilm B46 and Cimar UK B58.
For further information, interview opportunities or accompanying graphics please contact: Georgina Pavelin – Mixed Media ([email protected])
About Scribetech and Augnito
Scribetech (UK) Ltd. is a clinical voice solutions and disruptive technology provider. Founded in 2001, the company has accumulated two decades of experience as an approved supplier of clinical transcription services to the NHS and private healthcare providers.
Now, this expertise has been combined with 8 years of AI research and development partnerships established with engineers, analysts, and clinicians. The result is Augnito: an innovative, secure, cloud-based clinical speech recognition solution. Augnito brings seamless speech-enablement to daily workflows. All with 99% at-the-cursor accuracy, support for multiple medical specialities and no need for voice profile training. www.scribetech.co.uk/augnito-speechrecognition
The United Kingdom Imaging & Oncology Congress (UKIO) is the permanent amalgamation of two well-known conferences – the UK Radiological Congress (UKRC) and the UK Radiation Oncology Conference (UKRO). 2019 was the first year that this unified event ran as UKIO. In 2020 and 2021, UKIO ran as an online event. In 2022, the Congress will return as an in-person event. This annual event consists of a three-day multidisciplinary scientific congress with a programme that showcases the most cutting-edge content for a multidisciplinary audience that addresses the medical, scientific, educational and management issues in the diverse fields of diagnostic imaging, oncology, and radiological sciences. Alongside this is a large professional exhibition of the latest state-of-the-art equipment, services and technology available in the industry. The event attracts around 2,000 attendees. The 2022 theme is Harnessing disruption: Clinical excellence in a time of chaos. https://www.ukio.org.uk/